Revenue
2011
2012
2013
2014
2015
2016
2017
2018
BIO-PATH HOLDINGS, INC. (BPTH)
Price—Loading quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
Free cash flow
2014
2015
2016
2017
2018
2019
2021
2022
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0 | $37,000 | $13,000 | $0 | $0 | $0 | $0 | $0 | — |
| Research & development | $7.3M | $11.6M | $9.2M | $5.9M | $6.6M | $4.6M | $4.6M | $5.5M | $5.5M | $3.0M | $1.6M | $1.5M | $1.1M | — | — |
| Operating expenses | $12.0M | $15.8M | $13.9M | $10.4M | $10.9M | $8.7M | $8.6M | $9.0M | $8.5M | $5.5M | $4.5M | $3.3M | $2.6M | $2.4M | $2.3M |
| Operating income | −$12.0M | −$15.8M | −$13.9M | −$10.4M | −$10.9M | −$8.7M | −$8.6M | −$9.0M | −$8.5M | −$5.5M | −$4.5M | −$3.3M | −$2.6M | −$2.4M | −$2.3M |
| EBITDAderived | — | — | — | — | — | −$8.6M | −$8.2M | — | — | — | −$3.3M | −$2.2M | −$1.7M | — | — |
| Net income | −$9.9M | −$16.1M | −$13.9M | −$10.4M | −$10.9M | −$8.6M | −$8.6M | −$7.0M | −$6.8M | −$5.5M | −$4.5M | −$3.3M | −$2.6M | −$2.4M | −$2.1M |
| Basic EPSper diluted share | -$4.12 | -$33.63 | -$38.12 | -$1.55 | -$2.83 | -$3.24 | -$14.38 | -$15.99 | -$0.73 | -$0.06 | -$0.05 | -$0.05 | -$0.04 | -$0.04 | -$0.04 |
| Diluted EPSper diluted share | -$4.12 | -$33.63 | -$38.12 | -$1.55 | -$2.83 | -$3.24 | -$14.38 | -$15.99 | -$0.73 | -$0.06 | -$0.05 | -$0.05 | -$0.04 | -$0.04 | -$0.04 |